Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging

[1]  C. Olanow.  Magnetic resonance imaging in parkinsonism. , 1992, Neurologic clinics.

[2]  Eri Shibata,et al.  Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications , 2008, Neuroreport.

[3]  Yi-Hsin Weng,et al.  Parkinson disease: diagnostic utility of diffusion kurtosis imaging. , 2011, Radiology.

[4]  G A Johnson,et al.  MRI of brain iron. , 1986, AJR. American journal of roentgenology.

[5]  C. Marsden.  Parkinson's disease , 1940, The Lancet.

[6]  D B Hinshaw,et al.  Effects of the interaction between ferric iron and L‐dopa melanin on T1 and T2 relaxation times determined by magnetic resonance imaging , 1992, Magnetic resonance in medicine.

[7]  W. Koller,et al.  An algorithm (decision tree) for the management of Parkinson’s disease (2001): , 1998, Neurology.

[8]  W. Jost.  Autonomic dysfunctions in idiopathic Parkinson's disease , 2003, Journal of Neurology.

[9]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[10]  S. Shimohama,et al.  Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease , 2009, European journal of neurology.

[11]  David M. A. Mann,et al.  Possible role of neuromelanin in the pathogenesis of Parkinson's disease , 1983, Mechanisms of Ageing and Development.

[12]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[13]  Yasuo Terayama,et al.  Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease , 2006, Neuroreport.

[14]  K. Kashihara,et al.  Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease , 2011, Journal of Clinical Neuroscience.

[15]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[16]  Yasuo Terayama,et al.  Use of Neuromelanin-Sensitive MRI to Distinguish Schizophrenic and Depressive Patients and Healthy Individuals Based on Signal Alterations in the Substantia Nigra and Locus Ceruleus , 2008, Biological Psychiatry.

[17]  David Oakes,et al.  (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. , 2004, Archives of neurology.

[18]  W. Birkmayer,et al.  Dopamine action and disorders of neurotransmitter balance. , 1987, Gerontology.

[19]  Dorothee P Auer,et al.  T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[20]  R Weissleder,et al.  Paramagnetic metal scavenging by melanin: MR imaging. , 1997, Radiology.

[21]  Eri Shibata,et al.  Reduced signal of locus ceruleus in depression in quantitative neuromelanin magnetic resonance imaging , 2007, Neuroreport.

[22]  M Hutchinson,et al.  Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. , 2000, AJNR. American journal of neuroradiology.